Resident Ryan Thomas, MD, and Susan Waltz, PhD, have found that blocking the RON receptor with targeted antibodies killed more cancer cells than standard treatments for pancreatic cancer.
Ryan Thomas, MD, and Susan Waltz, PhD
PHOTO CREDIT: This photo is the property of the University of Cincinnati. Use of this photo requires credit to the University of Cincinnati. If you have any questions, please contact Academic Health Center public relations at (513) 558-4553 or email@example.com.